What is a ‘failure’ of bisphosphonate therapy for osteoporosis?

John J. Carey

What is a ‘failure’ of bisphosphonate therapy for osteoporosis?

John J. Carey, MD
John J. Carey
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation
MD
- Find this author on Google Scholar
- Find this author on PubMed
- Search for this author on this site
- For correspondence: [email protected]

Cleveland Clinic Journal of Medicine
November 2005,
72
(11)
1033-1039;

ABSTRACT

Assessing the effectiveness of bisphosphonate therapy is problematic. Bone mineral density and markers of bone turnover are often used, but the true measure is prevention of new fractures.

PDF

Previous Next

In this issue

Print
Download PDF
Article Alerts

Alerts for this Article

User Name *

Password *

Sign In to Email Alerts with your Email Address
Email *
Email Article

Email This Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following
What is a ‘failure’ of bisphosphonate therapy for osteoporosis?
Message Subject
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Citation Tools
What is a ‘failure’ of bisphosphonate therapy for osteoporosis?

John J. Carey

John J. Carey

Cleveland Clinic Journal of Medicine

November 2005,

72

(11)

1033-1039;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Share
Share This Article
What is a ‘failure’ of bisphosphonate therapy for osteoporosis?

John J. Carey

John J. Carey

Cleveland Clinic Journal of Medicine

November 2005,

72

(11)

1033-1039;

Share This Article:
Post